VALANX Biotech

Superpowering proteins.

Company Details

Valanx Biotech is a university spin-out offering a patented method for high-efficiency protein conjugation for cancer drug targeting and other uses.

  • Pitch Video

Company People

Adam Martak

Adam Martak
Business Development Manager

Patrik Fladischer

Patrik Fladischer
CSO

Michael Lukesch

Michael Lukesch
CEO

VALANX Biotech News

VIEW ALL

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.